Shaping the Future of Cardiovascular Disease by 3D Printing Applications in Stent Technology and its Clinical Outcomes

Cardiovascular disease (CVD) is a leading cause of death worldwide. In recent years, 3D printing technology has ushered in a new era of innovation in cardiovascular medicine. 3D printing in CVD management encompasses various aspects, from patient -specific models and preoperative planning to customized medical devices and novel therapeutic approaches. Instent technology, 3D printing has revolutionized the design and fabrication of intravascular stents, offering tailored solutions for complex anatomies and individualized patient needs. The advantages of 3D-printed stents, such as improved biocompatibility, enhanced mechanical properties, and reduced risk of in-stent restenosis. Moreover, the clinical trials and case studies that shed light on the potential of 3D printing technology to improve patient outcomes and revolutionize the field has been comprehensively discussed. Furthermore, regulatory considerations, and challenges in implementing 3D-printed stents in clinical practice are also addressed, underscoring the need for standardization and quality assurance to ensure patient safety and device reliability. This review highlights a comprehensive resource for clinicians, researchers, and policymakers seeking to harness the full potential of 3D printing technology in the fight against CVD. (Curr Probl Cardiol 2024;49:102039.)

Automated summary

3D printing technology has brought innovation in the field of cardiovascular medicine, especially in the management of cardiovascular disease (CVD). It has revolutionized the design and fabrication of intravascular stents, providing tailored solutions for complex anatomies and individualized patient needs. The advantages of 3D-printed stents include improved biocompatibility, enhanced mechanical properties, and reduced risk of restenosis. However, there are regulatory considerations and challenges in implementing 3D-printed stents in clinical practice.